Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
348,143
-
Shares change
-
-18,967
-
Total reported value, excl. options
-
$887,987
-
Value change
-
-$63,874
-
Number of buys
-
8
-
Number of sells
-
6
-
Price
-
$2.55
Institutional Holders of Predictive Oncology Inc. - COM (POAI) as of Q1 2024
17 filings reported holding POAI - Predictive Oncology Inc. - COM as of 31 Mar 2024.
Predictive Oncology Inc. - COM (POAI) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 348,143 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, RAYMOND JAMES & ASSOCIATES, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, CARNEGIE MELLON UNIVERSITY, Tower Research Capital LLC (TRC), UBS Group AG, OSAIC HOLDINGS, INC., and PSI Advisors, LLC.
This table shows the top 13 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.